As the 2020 pandemic became a distant memory and millions of Americans returned back to their old lives, some were left ...

In the early days of the COVID-19 pandemic, Moderna (NASDAQ: MRNA) was a top performer, from both a share-price and an ...

Kennedy Jr. as Health and Human Services (HHS) secretary, supporters of his "Make America Healthy Again" (MAHA) movement ...

The revelations coming from a major new study are nothing short of alarming. Recent findings reveal that the Covid mRNA “vaccines” may inflict serious harm on people’s immune systems and overall ...

Advancements in mRNA vaccine technology are reshaping medicine, addressing challenges and expanding applications from ...

With groundbreaking innovations in vaccines and immunotherapy, Medigen Biomedical Group is revolutionizing healthcare, and ...

Researchers from the International Institute of Molecular and Cell Biology in Warsaw (IIMCB) have described a new mechanism ...

Furthering its goal to grow the reach of its mRNA vaccines and guard against future pandemics, Moderna cleared a key ...

GSK GSK and Pfizer PFE announced that the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on ...

The U.S. government continues to end contracts related to the $5 billion Project NextGen initiative, this time terminating ...

Researchers working on mRNA vaccines fear federal funding might be halted, with many looking to move projects abroad ...

US mRNA specialist Moderna (Nasdaq: MRNA) has announced that its manufacturing facility in the UK has been granted a manufacturer’s license by the Medicines and Healthcare products Regulatory Agency ...